Security key
51654W101
Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN)
CUSIP: 51654W101
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 2,280,306
- Total 13F value
- $6,910,016
- Share change
- -4,043
- SEC-reported price per share
- $3.03
- Number of holders
- 33
- Value change
- -$64,644
- Number of buys
- 12
- Number of sells
- 13
- Shares outstanding
- 12,828,947
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
33
Top holders
10
LTRN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Lantern Pharma Inc. SEC filings
Lantern Pharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 51654W101
Recent filing periods:
Ownership snapshot
Top reported holders of LTRN - Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aaron G.l. Fletcher
Disclosed value leader
BIOS Capital Management, LP
Comparable rows
15/15
Latest evidence
30 Sep 2025
3/4/5
13F
Lead comparable stake: 8.4%
Showing 1-6 of 15 holder rows.
Quick read
Aaron G.l. Fletcher leads the comparable SEC ownership view at 8.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aaron G.l. Fletcher's linked filing trail.
Comparable ownership
Top 5
Aaron G.l. Fletcher
8.4%
Leslie W. Kreis
8.4%
BIOS Capital Management, LP
7.9%
VANGUARD GROUP INC
3%
CM Management, LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aaron G.l. Fletcher |
3/4/5
10%+ Owner
|
8.4%
|
$3,344,781
1,075,952 shares
|
— | 13 Jun 2025 |
| Leslie W. Kreis |
3/4/5
10%+ Owner
|
8.4%
|
$3,344,781
1,075,952 shares
|
— | 13 Jun 2025 |
| BIOS Capital Management, LP |
13F
Company
|
7.9%
|
$4,418,360
1,015,715 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$1,670,578
384,041 shares
|
— | 30 Sep 2025 |
| CM Management, LLC |
13F
Company
|
1.8%
|
$978,750
225,000 shares
|
— | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.78%
|
$435,435
100,100 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
2,280,306
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q4 2025 holders
33
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend